Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (201-210 of 272) with videos related to

Pageof 28
Sort By:
Plos One|October 3, 2013
Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinomaJuana Dornbusch, Aristeidis Zacharis, Matthias Meinhardt, et al.
Asian Journal of Andrology|January 5, 2017
Level of education and mortality after radical prostatectomyMichael Froehner, Rainer Koch, Stefan Propping, et al.
International Journal of Oncology|September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growthShuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
Urologic Oncology|January 9, 2007
Changing comorbidity classification patterns at radical prostatectomy during a 10-year periodMichael Froehner, Bernd Garbrecht, Oliver W Hakenberg, et al.
Urologia Internationalis|October 30, 2019
Long-Term Mortality in Patients with Positive Lymph Nodes at the Time of Radical ProstatectomyMichael Froehner, Rainer Koch, Samaneh Farahzadi, et al.
European Urology|March 24, 2004
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancerManfred P Wirth, Lothar Weissbach, Franz-Josef Marx, et al.
The Prostate|July 15, 2003
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8Andrea Kiessling, Susanne Füssel, Marc Schmitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2005
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer ProgrammeChris J Tyrrell, Heather Payne, William A See, et al.
Cancer Letters|February 7, 2006
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNASusanne Fuessel, Jana Herrmann, Shuangli Ning, et al.
Cancer Letters|June 28, 2005
Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairsSusanne Fuessel, Bernd Weigle, Uta Schmidt, et al.
Pageof 28

Showing results (201-210 of 272) with videos related to

Sort By:
Pageof 28
Plos One|October 3, 2013
Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinomaJuana Dornbusch, Aristeidis Zacharis, Matthias Meinhardt, et al.
Asian Journal of Andrology|January 5, 2017
Level of education and mortality after radical prostatectomyMichael Froehner, Rainer Koch, Stefan Propping, et al.
International Journal of Oncology|September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growthShuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
Urologic Oncology|January 9, 2007
Changing comorbidity classification patterns at radical prostatectomy during a 10-year periodMichael Froehner, Bernd Garbrecht, Oliver W Hakenberg, et al.
Urologia Internationalis|October 30, 2019
Long-Term Mortality in Patients with Positive Lymph Nodes at the Time of Radical ProstatectomyMichael Froehner, Rainer Koch, Samaneh Farahzadi, et al.
European Urology|March 24, 2004
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancerManfred P Wirth, Lothar Weissbach, Franz-Josef Marx, et al.
The Prostate|July 15, 2003
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8Andrea Kiessling, Susanne Füssel, Marc Schmitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2005
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer ProgrammeChris J Tyrrell, Heather Payne, William A See, et al.
Cancer Letters|February 7, 2006
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNASusanne Fuessel, Jana Herrmann, Shuangli Ning, et al.
Cancer Letters|June 28, 2005
Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairsSusanne Fuessel, Bernd Weigle, Uta Schmidt, et al.
Pageof 28